Mirum Pharmaceuticals Inc (MIRM) Q3 2026 Earnings Call Highlights: Raised Guidance, $500 ...
Mirum Pharmaceuticals Inc (MIRM) lifted full-year net product sales guidance to $715-$720 million after Q3 sales of $186 million, with nine-month revenue already matching all of 2025. Related Stocks: MIRM ,